机译:阿格列汀对血管紧张素Ⅱ1型受体的阻断对DPP-4的抑制作用通过上调SDF-1α改善2型糖尿病初发肾病患者的蛋白尿
Division of Endocrinology, Metabolism and Geriatric Medicine, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan;
Division of Internal Medicine, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Gastroenterology, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Gastroenterology, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Internal Medicine, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Internal Medicine, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Gastroenterology, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Gastroenterology, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Gastroenterology, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Gastroenterology, Honjo Daiichi Hospital, Yurihonjo 015-8567, Japan;
Division of Endocrinology, Metabolism and Geriatric Medicine, Akita University Graduate School of Medicine, Akita 010-8543, Japan;
Division of Endocrinology, Metabolism and Geriatric Medicine, Akita University Graduate School of Medicine, Akita 010-8543, Japan;
Diabetic nephropathy; DPP-4 inhibition; Glucagon-like peptide-1; Oxidative stress; SDF-1α;
机译:阿格列汀对血管紧张素II 1型受体的阻断对DPP-4的抑制作用通过上调SDF-1α改善2型糖尿病初发肾病患者的蛋白尿
机译:ACE抑制和血管紧张素II受体阻滞剂对I型糖尿病肾病患者的累加作用。
机译:ACE抑制和血管紧张素II受体阻滞剂对I型糖尿病肾病患者的累加作用
机译:血管紧张素II型1受体封闭因子的抗心肌壮丽的衰减:2型受体的作用
机译:中国2型糖尿病肾病患者的血流介导的扩张。
机译:(原)肾素受体的抑制有助于糖尿病肾病中血管紧张素II 1型受体阻滞的肾保护作用。
机译:DPP-4抑制Alogliptin在血管紧张素II型1型受体阻滞的顶部改善白蛋白尿嘧啶在2型糖尿病患者中的SDF-1α上调,初期肾病患者